Clinical Trial of TQB2618 Injection Combined With TQB2450 Injection in Patients With Advanced Solid Tumors
Clinical trial NCT05645315 · UNKNOWN
Trial details
- NCT number
- NCT05645315
- Sponsor
- Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2022-04-28
- Primary completion
- 2023-12-01
- Enrollment
- 127
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.